Shots: Biogen’s decision of acquisition of TMS-007 based on the safety, imaging, and clinical outcome data from the P-IIa study which showed positive impacts on both blood vessel reopening in […]readmore
Tags : Acute Ischemic Stroke
Shots: The P-III THALES study involves assessing of Brilinta (180mg as a loading dose followed by 90mg, bid) + aspirin vs aspirin as monothx. in 11,000 patients with non-cardioembolic acute […]readmore
Shots: The US FDA has accepted sNDA and granted PR for Brilinta to reduce subsequent stroke in patients experiencing an acute ischemic stroke or TIA. The sNDA is based on […]readmore